Louisiana State Employees Retirement System’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Other funds holding EGRX
BIP
Louisiana State Employees Retirement System's EGRX Position: Q3 2022 in Review
Louisiana State Employees Retirement System sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2022, closing a stake of 5,400 shares — an estimated $235K sold.
Louisiana State Employees Retirement System first reported a position in EGRX in Q3 2016 and held it in 18 quarters. The position peaked at $340K in Q3 2018. 153 funds tracked by Wall St. Rank hold EGRX as of Q3 2022.
- Louisiana State Employees Retirement System reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
- Louisiana State Employees Retirement System sold 5,400 Eagle Pharmaceuticals, Inc. shares in Q3 2022, an estimated $235K.
- Louisiana State Employees Retirement System first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2016 and held it in 18 quarters.
- Louisiana State Employees Retirement System's Eagle Pharmaceuticals, Inc. position peaked at $340K in Q3 2018.
- 153 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2022.
Based on Louisiana State Employees Retirement System's 13F filing for Q3 2022, filed 19 Oct 2022.